Shares of Abbott Laboratories (ABT) are falling about 4 percent on Thursday morning trading after the company announced a decline in first-quarter earnings to $1.07 billion, or $0.61 per share, from last year's $1.32 billion, or $0.76 per share.
The company's stock is currently trading at $97.21, down 4.21 percent or $4.27, over the previous close of $101.56 on the New York Stock Exchange. It has traded between $96.82 and $139.06 in the past one year.
However, the company's revenue for the period rose to $11.16 billion from $10.35 billion in the previous year. Additionally, the company stated that it now projects full-year 2026 adjusted EPS of $5.38 to $5.58.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.